MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial – Nature
المصدر: Google News — Pakistan / HEALTH
0
Views
المصدر: Google News — Pakistan / HEALTH